Shanghai Junshi Biosciences Competitors and Similar CompaniesClear all
Shanghai Junshi Biosciences's competitors and similar companies include ZAI Lab, Jiangsu Hansoh Pharmaceutical Group, Takeda and Biocon.
 Shanghai Junshi Biosciences Shanghai Junshi Biosciences (上海君實生物醫藥科技) is a biopharmaceutical company focused on the treatment of cancer, autoimmune, and metabolic diseases. |  ZAI Lab Zai Lab is a biopharmaceutical company dedicated to discovering, developing, and commercializing medicines for cancer, autoimmune and infectious diseases. |  Takeda Takeda Pharmaceutical (武田薬品工業株式会社) is a biopharmaceutical company engaged in the research, development, production, and commercialization of pharmaceutical products. | |||
Founding Date | Founding Date 2012 | Founding Date 2014 | Founding Date 1995 | Founding Date 1781 | Founding Date 1978 |
Type | Type Public | Type Public | Type Public | Type Public | Type Public |
Tags | |||||
Locations | Locations Shanghai, CN HQ | Locations CN HQ Suzhou, CN Hong Kong, HK Taipei, TW Cambridge, US Menlo Park, US | Locations Lianyungang Shi, CN HQ | Locations Bengaluru, IN HQ Bengaluru, IN Nanakramguda, IN Dublin, IE Kuala Lumpur, MY Puchong, MY Delémont, CH see more | |
Employees | Employees 2,578 | Employees 1,869 | Employees 8,989 | Employees 47,4554% decrease | Employees 16,5612% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) 3.2 b | Valuation ($) N/A | Valuation ($) 43.7 b | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) ¥2.4b (FY, 2025) | Revenue (est.) $460.2m (FY, 2025) | Revenue (est.) ¥15b (FY, 2025) | Revenue (est.) ¥4.6t (FY, 2025) | Revenue (est.) ₹167.8b (FY, 2026) |
Cost of goods | Cost of goods ¥466.5m (FY, 2025) | Cost of goods $190.5m (FY, 2025) | Cost of goods ¥1.1b (FY, 2025) | Cost of goods ¥818.8b (FY, 2025) | Cost of goods ₹56.9b (FY, 2026) |
Gross profit | Gross profit ¥2b (FY, 2025) | Gross profit $269.6m (FY, 2025) | Gross profit ¥14b (FY, 2025) | Gross profit ¥3.8t (FY, 2025) | Gross profit ₹115.8b (FY, 2026) |
Net income | Net income (¥1b) (FY, 2025) | Net income ($175.5m) (FY, 2025) | Net income ¥5.6b (FY, 2025) | Net income ¥108.1b (FY, 2025) | Net income ₹3.7b (FY, 2026) |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised $ 985m | Total funding raised N/A | Total funding raised $ 57.8m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
ZAI Lab
HQ
CN
Employees
1,869
Zai Lab is a biopharmaceutical company dedicated to discovering, developing, and commercializing medicines for cancer, autoimmune and infectious diseases.
View company
Jiangsu Hansoh Pharmaceutical Group
HQ
Lianyungang Shi, CN
Employees
8,989
Jiangsu Hansoh Pharmaceutical Group is a pharmaceutical company.
View companyTakeda
HQ
Tokyo, JP
Employees
47,455↓ 4% decrease
Takeda Pharmaceutical (武田薬品工業株式会社) is a biopharmaceutical company engaged in the research, development, production, and commercialization of pharmaceutical products.
View company
Biocon
HQ
Bengaluru, IN
Employees
16,561↑ 2% increase
Biocon is a company that develops and manufactures biopharmaceutical products.
View company